申请人:Korea Research Institute of Chemical Technology
公开号:US05665738A1
公开(公告)日:1997-09-09
Novel imidazole derivatives of formula(I) inhibit effectively the action of angiotensin II and have a superior antihypertensive activity: ##STR1## wherein: A is a straight, branched or cyclic C.sub.1 -C.sub.6 alkyl group, or OR.sub.1 wherein R.sub.1 is a hydrogen, or a straight, branched or cyclic C.sub.1 -C.sub.6 alkyl radical; B is a halogen, CF.sub.3 or CF.sub.2 CF.sub.3 ; X is N or N-oxide; Y is --CH.sub.2 --, --CH(OR.sub.1)-- wherein R.sub.1 is the same as defined above, or --C(.dbd.O)--; n is 0 or an integer of 1 to 4; Z is a halogen, --OH, --OR.sub.1, --NR.sub.1 R.sub.2, --N(.dbd.O)R.sub.3 R.sub.4, --C(.dbd.O)R.sub.1, --C(.dbd.O)OR.sub.1, --CH(OR.sub.1).sub.2 or --C(.dbd.O)N.sub.1 N.sub.2 wherein R.sub.1 is the same as defined above, R.sub.2 is, independently of R.sub.1, a hydrogen, or a straight, branched or cyclic C.sub.1 -C.sub.6 alkyl radical, and R.sub.3 and R.sub.4 are independently a straight, branched or cyclic C.sub.1 -C.sub.6 alkyl radical; and D is a hydrogen, or a straight, branched or cyclic C.sub.1 -C.sub.6 alkyl radical.
新型咪唑衍生物的化学式(I)有效抑制血管紧张素II的作用,并具有优越的降压活性:##STR1## 其中:A为直链、支链或环状的C.sub.1 -C.sub.6烷基基团,或OR.sub.1,其中R.sub.1为氢,或直链、支链或环状的C.sub.1 -C.sub.6烷基基团;B为卤素、CF.sub.3或CF.sub.2 CF.sub.3;X为N或N-氧化物;Y为--CH.sub.2--、--CH(OR.sub.1)--其中R.sub.1与上述定义相同,或--C(.dbd.O)--;n为0或1到4的整数;Z为卤素、--OH、--OR.sub.1、--NR.sub.1 R.sub.2、--N(.dbd.O)R.sub.3 R.sub.4、--C(.dbd.O)R.sub.1、--C(.dbd.O)OR.sub.1、--CH(OR.sub.1).sub.2或--C(.dbd.O)N.sub.1 N.sub.2其中R.sub.1与上述定义相同,R.sub.2是与R.sub.1独立的氢,或直链、支链或环状的C.sub.1 -C.sub.6烷基基团,R.sub.3和R.sub.4独立地是直链、支链或环状的C.sub.1 -C.sub.6烷基基团;D是氢,或直链、支链或环状的C.sub.1 -C.sub.6烷基基团。